NDAOPHTHALMICSUSPENSION/DROPS
Approved
Jun 1963
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
MAXITROL (neomycin sulfate, polymyxin b sulfate and dexamethasone) by Novartis is corticosteroid hormone receptor agonists [moa]. Approved for corticosteroid [epc]. First approved in 1963.
Drug data last refreshed 15h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MAXITROL is a fixed-dose ophthalmic suspension combining two antibiotics (neomycin and polymyxin B) with the corticosteroid dexamethasone, approved in 1963. It treats bacterial eye infections and inflammation by providing broad-spectrum antimicrobial coverage while reducing corticosteroid-mediated ocular inflammation. The corticosteroid component works via hormone receptor agonism to suppress inflammatory responses.
LOE Approaching
Minimal commercial spend ($3K) signals a mature, low-revenue product with contracted team size and limited growth investment.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
MAXITROL presents limited career advancement opportunities due to its minimal commercial spend, LOE-approaching status, and zero linked job postings. Roles associated with this product are primarily maintenance-focused, involving regulatory compliance, supply chain management, and customer support rather than innovation or growth.
Regulatory Affairs Specialist
Worked on MAXITROL at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.